医学
血管通路
背景(考古学)
端口(电路理论)
静脉通路
重症监护医学
并发症
养生
医疗保健
外科
卫生专业人员
静脉治疗
血管疾病
集合(抽象数据类型)
医疗急救
患者安全
套管
作者
Gema Munoz-Mozas,Janice Gabriel,Santiago Vecino Vázquez
出处
期刊:British journal of nursing
[Mark Allen Group]
日期:2026-07-16
卷期号:35 (14): S24-S30
标识
DOI:10.12968/bjon.2026.0051
摘要
There are two classifications of vascular access devices: peripheral (including peripheral intravenous cannula) and central vascular access devices (including non-tunnelled central venous catheters, peripherally inserted central catheters, skin tunnelled central venous catheters and implantable ports). Selecting the most appropriate device can be challenging for healthcare professionals, particularly in the context of long-term treatment, such as chemotherapy, prolonged sequential antibiotic therapy for pulmonary disease or iterative immunoglobulin infusion. When choosing a device, healthcare professionals should consider the indication, treatment regimen and complication rate of each device. For patients requiring sequential treatments lasting 3 months or longer, use of an implantable port is preferred, as it offers lower complication rates, improved patient comfort and greater cost-effectiveness. However, in some cases, skin tunnelled catheters or peripherally inserted central catheters may be indicated. In all situations, strict adherence to guidelines on device selection, insertion, removal and non-coring needle use is essential to minimise complications. This article provides an overview of central venous access devices, with a particular focus on the benefits of implantable ports for long-term care and the role of the Safetouch Huber Infusion Set in facilitating access to implantable ports. Use of the Safetouch Huber Infusion Set is further illustrated in two real-world case studies.
科研通智能强力驱动
Strongly Powered by AbleSci AI